HILL STEPHEN J. (Chief Technical Ops. Officer) sold 5.6% of their position (989.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $15.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/25/2026ACC: 0001866154-26-000006
Officer· Chief Technical Ops. Officer
Since Jun 2021
-989.00
Net shares
Net seller
$15.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
989.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−989.00
Price / share
$15.54
Trade value
$15.37K
% of position
5.6%
8/21/2026
17.80K→16.82K
Total
Net shares
−989.00
Net value
-$15.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2026 | S · Sale | −989.00 | $15.54 | $15.37K | 5.6% | 17.80K | 16.82K |
| Total | −989.00 | -$15.37K | ||||||
Derivative Transactions0
No derivative transactions reported